Network Penetration Testing for Biotech companies in Detroit (MI)
Network Penetration Testing for Biotech Companies in Detroit (MI)
Biotech and life sciences organizations in Detroit and across Michigan handle some of the most sensitive data in the region—clinical trial results, genomic data, proprietary formulations, connected lab equipment, and protected health information (PHI). This makes them a high‑value target for ransomware groups, IP thieves, and nation‑state actors.
Common attack methods include phishing emails, malware, password attacks, SQL injection against lab and patient portals, and exploitation of exposed lab systems or cloud environments. The average cost of a data breach reached USD $4.24M in 2021, and biotech breaches often exceed that due to regulatory penalties, lost research, and damage to investor confidence.
For Detroit biotech companies—from startup labs in Midtown to established manufacturers along the I‑94 corridor—this means cybersecurity cannot be a one‑time project. Your environment, threat landscape, and regulatory obligations (HIPAA, FDA expectations for computerized systems, data integrity requirements for GxP) evolve constantly. Regular, independent security assessments are essential to verify that your existing controls actually work under pressure.
What Is Network Penetration Testing in a Biotech Context?
Network penetration testing (often called a “pentest”) is a controlled, ethical hacking exercise where security professionals simulate real‑world attacks against your environment. For biotech organizations in Detroit, this typically includes:
Corporate networks – offices, research sites, HQ, and remote users
Cloud and hybrid environments – platforms hosting research data, analytics, and collaboration tools
Lab networks and OT/IoT devices – LIMS, lab instruments, sequencing machines, manufacturing control systems, and connected medical devices
The objective is to identify and safely exploit weaknesses before an attacker does. The outcome gives leadership a clear, prioritized view of:
Which vulnerabilities put IP, PHI, and critical research data at risk
How far an attacker could move inside the environment after a single compromised account or device
How effective your monitoring, incident response, and access controls really are
Where improvements are needed to support compliance and due diligence for regulators, partners, and investors
Detroit & Michigan Biotech Penetration Testing Experience
OCD Tech provides network penetration testing and IT security assessments to biotech, pharmaceutical, med‑tech, and healthcare organizations in Detroit and across Michigan. Our team combines:
Hands‑on offensive security expertise (Red Team / Ethical Hacking)
Experience with regulated and validated environments used in research and manufacturing
Knowledge of HIPAA, GxP, FDA‑regulated systems, and data integrity expectations
The result is a practical, business‑focused penetration test that does more than list vulnerabilities. We provide clear guidance on how to remediate gaps in a way that fits your lab operations, change‑control processes, and production constraints.
Our Network Penetration Testing Methodology
OCD Tech follows a proven, structured methodology designed to mirror how real attackers operate—while maintaining strict safety controls appropriate for biotech environments:
Passive Reconnaissance – Quietly mapping your external footprint, exposed services, and data leaks related to your organization, research programs, and staff.
Active Reconnaissance – Safely scanning networks and applications to identify vulnerable systems, misconfigurations, and weak authentication controls.
Social Engineering – Optionally testing your users (e.g., phishing simulations) to assess how easily attackers could gain initial access via staff, contractors, or vendors.
Exploitation – Attempting controlled exploitation of identified weaknesses to demonstrate realistic risk to lab systems, data repositories, and business operations.
Post‑Exploitation – Assessing what an attacker can access after a foothold: internal data, credentials, lab networks, and cloud environments.
Privilege Escalation – Testing whether a low‑level account can be used to obtain administrative or domain‑level control.
Lateral Movement – Evaluating how far an attacker could move between research, corporate, and production segments if segmentation and controls fail.
Maintain Access – Demonstrating techniques attackers use to persist in your environment, so you can strengthen detection and response.
Cover Tracks – Showing how logs and evidence could be altered or removed, highlighting gaps in monitoring and forensic readiness.
Reporting & Executive Briefing – Delivering a clear, prioritized report and walkthrough tailored for both technical teams and non‑technical leadership, including remediation guidance and roadmap recommendations.
Throughout the engagement, we coordinate closely with your team to avoid disrupting critical experiments, manufacturing runs, or clinical operations.
National Reach
While we work extensively with biotech companies in Detroit and throughout Michigan, OCD Tech also provides network penetration testing services across the U.S., including Boston (MA), New York City (NY), Washington DC, Philadelphia (PA), Dallas (TX), Los Angeles (CA), Chicago (IL), and Baltimore (MD).
Contact Our Detroit Network Penetration Testing Consultants
OCD Tech delivers network penetration testing, IT security assessments, and cybersecurity consulting to biotech and life sciences organizations in Detroit and across Michigan. If you would like to discuss a penetration test for your lab, research, or corporate environment, please complete the form below and a team member will contact you shortly.

